The U.S. Department of Defense will help capitalize defense technology, biotechnology and quantum science companies in an effort to develop more next-generation weapons and military systems.The new Pentagon office “will help build an enduring technological advantage by partnering with private capital providers,” according a DOD announcement.The Pentagon said OSC will help fund next-gen biotech and defense firms “developing critical technologies vital to national security,” according to the announcement.“By working with the private capital markets and by partnering with our federal colleagues, OSC will address investment gaps and add a new tool to the Department’s investment toolbox.”Pentagon hopes proving longer-term funding will help more companies to transition technology into military capabilities and help with their capital needs.Our hope is that OSC will be able to strike its first deals by early next year.”According to the Pentagon, “the OSC will work across policy, acquisition, and research efforts to increase the amount of capital available to critical technology companies.”The efforts also aims to “scale investments” between the Defense Advanced Research Projects Agency (DARPA), the Defense Innovation Unit, which helps commercialize innovative technologies, and “critical technology” to reach production levels."